ZNF37A

mass-spec protein — tumor vs normal
Tumor vs Normalmass-specBox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, ZNF37A mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ZNF37A’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where ZNF37A mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF37A is over-expressed in tumor.

HNSC and LSCC are the cancer types where ZNF37A tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF37A mass-spec protein (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
HNSCAllAll+0.652.0296view →
LSCCAllAll+0.565.0104view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

ZNF37A–HNSC

Tumor-vs-normal mass-spec protein box plot for ZNF37A in HNSC.

Open the HNSC breakdown →

Exploration